Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China’s SFDA To Air Test Results Of Lethal Human Immunoglobin

This article was originally published in PharmAsia News

Executive Summary

Chinese authorities have completed a week-long test of human immunoglobin believed connected with six deaths in the Jiangxi Province. The State FDA recalled all 6,247 bottles of the suspected antibody produced by Jiangxi Boya Pharmaceutical. The test results have not been determined, but an SFDA spokeswoman said they would be released as soon as they are concluded. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068921

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel